Fibroblast-derived matrices-based human skin equivalent as an in vitro psoriatic model for drug testing

J Biosci. 2021;46:86.

Abstract

Psoriasis is a chronic skin disease characterized by thickening and disorganization of the skin's protective barrier. Although current models replicate some aspects of the disease, development of therapeutic strategies have been hindered by absence of more relevant models. This study aimed to develop and characterize an in vitro psoriatic human skin equivalent (HSE) using human keratinocytes HaCat cell line grown on fibroblasts-derived matrices (FDM). The constructed HSEs were treated with cytokines (IL-1α, TNF-α, IL-6, and IL22) to allow controlled induction of psoriasis-associated features. Histological stainings showed that FDMHSE composed of a fully differentiated epidermis and fibroblast-populated dermis comparable to native skin and rat tail collagen-HSE. Hyperproliferation (CK16 and Ki67) and inflammatory markers (TNF-α and IL-6) expression were significantly enhanced in the cytokine-induced FDM- and rat tail collagen HSEs compared to non-treated HSE counterparts. The characteristics were in line with those observed in psoriasis punch biopsies. Treatment with all-trans retinoic acid (ATRA) has shown to suppress these effects, where HSE models treated with both ATRA and cytokines exhibit histological characteristics, hyperproliferation and differentiation markers expression like non-treated control HSEs. Cytokine-induced FDM-HSE, constructed entirely from human cell lines, provides an excellent opportunity for psoriasis research and testing new therapeutics.

MeSH terms

  • Cell Differentiation / drug effects*
  • Cell Line
  • Cell Proliferation / drug effects*
  • Cytokines / pharmacology*
  • Fibroblasts / drug effects*
  • Humans
  • Keratolytic Agents / pharmacology
  • Psoriasis / drug therapy*
  • Tretinoin / pharmacology

Substances

  • Cytokines
  • Keratolytic Agents
  • Tretinoin